Home
Storia in 1 fonti
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
J.P. Morgan analyst Benjamin Rossi maintained a Buy rating on Tenet Healthcare yesterday and set a price target of $260.00. The company’s shares...
Raccontata da
markets.businessinsider.com
Timeline cronologica
- ·
J.P. Morgan Keeps Their Hold Rating on Universal Health (UHS)
In a report released yesterday, Benjamin Rossi from J.P. Morgan maintained a Hold rating on Universal Health, with a price target of $205.00. Th...
- ·
J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)
J.P. Morgan analyst Anupam Rama maintained a Buy rating on First Tracks Biotherapeutics Inc yesterday and set a price target of $30.00. The comp...
- ·
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
J.P. Morgan analyst Benjamin Rossi maintained a Buy rating on Tenet Healthcare yesterday and set a price target of $260.00. The company’s shares...